Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Nov 2018 03:01 PM
RNS
Amendment to Executive Director Service Terms
26 Nov 2018 03:00 PM
RNS
Announcement of Strategic Review
26 Nov 2018 12:30 PM
RNS
PDS Announces Merger with Edge Therapeutics
08 Nov 2018 07:00 AM
RNS
Vortex Improves CTC Enumeration with Impedance
01 Nov 2018 07:00 AM
RNS
Vortex and STRATEC Announce Global Partnership
22 Oct 2018 01:01 PM
RNS
Glycotest Completes $10m Series A Round with Fosun
22 Oct 2018 07:00 AM
RNS
Glycotest Completes $10m Series A Round with Fosun
28 Sep 2018 07:00 AM
RNS
Interim Results
20 Sep 2018 07:00 AM
RNS
ProAxsis Immunoassays Selected for Large Trial
15 Aug 2018 07:00 AM
RNS
Wanda Launches CareLink, New Digital Health App
02 Aug 2018 07:02 AM
RNS
ProAxsis Granted Third Respiratory Field CE Mark
02 Aug 2018 07:00 AM
RNS
Change of Adviser
18 Jul 2018 07:00 AM
RNS
Wanda Technology Enhancements
26 Jun 2018 04:24 PM
RNS
Grant of Options to Directors
21 Jun 2018 01:33 PM
RNS
Result of AGM
06 Jun 2018 07:00 AM
RNS
Bob Englert Appointed CEO of Vortex Biosciences
04 Jun 2018 07:00 AM
RNS
ProAxsis Wins Innovative Business of Year in NI
01 Jun 2018 07:00 AM
RNS
ProAxsis Awarded Invest NI Grant
22 May 2018 04:21 PM
RNS
Notice of AGM and Annual Report & Accounts
21 May 2018 07:00 AM
RNS
Wanda Announces Significant Data with Partner HRS
02 May 2018 07:00 AM
RNS
ProAxsis to Present New Data at ATS 2018
18 Apr 2018 05:08 PM
RNS
Directors Dealing Notification
16 Apr 2018 02:04 PM
RNS
Result of General Meeting
16 Apr 2018 07:25 AM
RNS
Vortex to Present 2 Posters at AACR
11 Apr 2018 11:39 AM
RNS
Result of Placing
03 Apr 2018 04:09 PM
RNS
Posting of Circular
29 Mar 2018 07:00 AM
RNS
Proposed Placing and Subscription
29 Mar 2018 07:00 AM
RNS
Full Year Results
19 Mar 2018 07:00 AM
RNS
Wanda Expanding to Orthopedic Analytics
13 Mar 2018 07:00 AM
RNS
Vortex Announces Partnership with BioView
15 Feb 2018 07:00 AM
RNS
ProAxsis Reports First NEATstik Sale
09 Feb 2018 07:00 AM
RNS
Vortex Releases Publication in Nature Scientific
16 Jan 2018 07:00 AM
RNS
NetScientific Portfolio Update
08 Jan 2018 07:00 AM
RNS
ProAxsis Achieves CE Mark for Plasmin Immunoassay
04 Jan 2018 07:00 AM
RNS
GlycotestT Completes Diagnostic Evaluation
12 Dec 2017 07:00 AM
RNS
Wanda Awarded Two Patents
21 Nov 2017 07:00 AM
RNS
ProAxsis: Sales Update
07 Nov 2017 07:00 AM
RNS
Vortex Announces First Commercial VTX-1 Sale
03 Nov 2017 11:00 AM
RNS
HRS Expands Use of Wanda to All Patients
02 Nov 2017 07:00 AM
RNS
Glycotest Adds Allowed Chinese Patent to Portfolio
01 Nov 2017 11:00 AM
RNS
Vortex Announces Liquid Biopsy Study in NPJ
30 Oct 2017 07:00 AM
RNS
ProAxsis Showcases ProteaseTag® Research at NACFC
27 Oct 2017 07:00 AM
RNS
ProAxsis Partnership - US National Jewish Health
25 Oct 2017 07:00 AM
RNS
Directorate Change
05 Oct 2017 07:00 AM
RNS
Glycotest Granted Japanese Patent
02 Oct 2017 07:00 AM
RNS
Wanda Awarded US Patent
28 Sep 2017 07:00 AM
RNS
2017 Interim Results
14 Sep 2017 07:00 AM
RNS
ProAxsis appoints Diagenics Limited as Distributor
11 Sep 2017 07:00 AM
RNS
ProAxsis Signs Partnership: Biotechnology Company
07 Sep 2017 07:00 AM
RNS
Notice of Interim Results

EMV Capital is a London venture capital company that invests in early-stage, IP-rich, technology and life sciences companies in the UK and internationally.

It is listed on AIM under the ticker EMVC.

EMVC share price launched at 1,620p in 2013.

UK 100

Latest directors dealings